美国艰难梭菌感染的分阶段流行史:1935年至今
本综述结合历史报告与监测数据,将美国艰难梭菌感染(CDI)描述为分阶段流行,目前处于减速阶段。CDI发病率在2010年前后达峰后下降,并从医疗相关转向社区获得性,诊断方法变化使各阶段发病率比较复杂化。
要点
- CDI在美国呈分阶段流行,当前处于减速阶段。
- 2010年前后发病率下降,社区获得性CDI占比上升。
- 诊断方法变化使不同阶段发病率比较复杂化。
核心结论
- 美国CDI目前处于减速阶段,特征为感染储库和可能的免疫增加。
- 未来CDI可能更偏向社区获得性和隐匿性,而非医院为主和暴发性。
研究设计与样本
- 综述结合历史报告与监测数据,将美国CDI描述为分阶段流行。
主要发现
- CDI在1978年至2010年峰值期间处于加速阶段,特征为氟喹诺酮耐药、产毒增多的菌株、大型医院暴发和发病率超过150/10万。
- 约2010年起CDI发病率下降,并从医疗相关转向社区获得性。
- 诊断方法变化使不同阶段发病率比较复杂化。
临床怎么用
- 临床应准备应对更偏向社区获得性和隐匿性的CDI,而非仅关注医院内暴发。
局限性
- 原文提及诊断方法变化使各阶段发病率比较复杂化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
This review combines historical reports and surveillance data to contextualize Clostridioides difficile infection (CDI) in the United States as a phased epidemic, currently in the deceleration phase. C. difficile was first isolated in 1935. During a prolonged emergence phase, the organism attracted limited clinical attention. In 1978, C. difficile was established as the cause of antibiotic-associated pseudomembranous colitis and from 1978 to a peak in 2010, CDI was in an acceleration phase characterized by fluoroquinolone-resistant, toxin-overproducing strains, large hospital outbreaks, and incidence rates over 150 per 100 000 population. Beginning around 2010, CDI incidence decreased, with a shift from healthcare-associated to community-acquired CDI. Changes in diagnostics complicate incidence comparison between phases; only recently is it apparent that CDI has entered a deceleration phase characterized by infectious reservoirs and possible increases in immunity. It may behoove us to prepare for a different kind of CDI: community-based and insidious rather than hospital-predominant and explosive.
引用
- Kar OB, Freedberg DE. The Phases of Clostridioides difficile Infection (CDI) in the United States: The History and Epidemiology of CDI From 1935 to Present. Clin Infect Dis. 2026. PMID: 42284457. doi:10.1093/cid/ciag363
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。